BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 26, 2004
View Archived Issues
Fluvastatin XL reduces coronary artery disease risk factor in diabetic patients
Read More
Protective effects of palifermin during chemotherapy/radiotherapy
Read More
Two series of DPP-IV inhibitors prepared and tested at Tanabe Seiyaku
Read More
Pfizer describes new CDK2/CDK4 inhibitors with utility in cancer therapy
Read More
Novartis and Scripps jointly describe new antitumor epothilones
Read More
Two novel series of GABA-A receptor ligands developed at Merck
Read More
New GSK-3beta inhibitors in early development at Mitsubishi Pharma
Read More
New tyrosine kinase inhibitors emerge from Merck R&D
Read More
Monoclonal antibody with broad HIV-neutralizing activity identified by NIH and NCI
Read More
Targeting IkappaB kinase for inflammation and pain therapy
Read More
European Commission approves extended labeling for Xenical
Read More
Positive phase III results for Velac
Read More
Allowance of IND for clinical testing of new HIV vaccine
Read More
Structural GenomiX enters drug discovery collaboration with Serono
Read More
Norak BioSciences completes screening collaboration with Sumitomo
Read More
IND filing for DB-289 as oral treatment for African sleeping sickness
Read More
Health Discovery and U. of Miami enter AIDS-related dementia agreement
Read More
Pamorelin LA receives approval in Germany
Read More
Orphan drug status for sodium thiosulfate
Read More
Encouraging preclinical data reported for glucosylceramide
Read More
European orphan drug status for Anatibant
Read More
New European phase II/III trial for Bexidem in bladder cancer
Read More
INDs filed for topical PEP-005
Read More
Fosrenol receives approval in Sweden
Read More
Comparative monkey studies successfully completed for Belerofon
Read More
Phase III results for anidulafungin plus liposomal amphotericin B
Read More
Interim data from HuMax-IL-15 phase II study in RA
Read More
Doxycycline hyclate reported safe and effective for rosacea
Read More
Effective maintenance of asthma control with a fluticasone propionate/salmeterol combination
Read More
Improved asthma control achieved with Symbicort single inhaler therapy
Read More
Olopatadine significantly improves the quality of life of patients with SAR
Read More
Low incidence of oropharyngeal side effects found with ciclesonide in asthma
Read More